Effect of lipidic factors on membrane cholesterol topology--mode of binding of theta-toxin to cholesterol in liposomes.
We have previously suggested the existence of two distinct states for cholesterol in cell membranes as revealed by high- and low-affinity binding sites for theta-toxin of Clostridium perfringens. In liposomes, phospholipid and cholesterol compositions, but not membrane protein composition, have been shown to be major determinants for the topology of membrane cholesterol. The effects of lipidic factors on cholesterol topology were investigated in detail by analyzing toxin binding to large unilamellar liposomes composed of cholesterol and phospholipids (neutral phospholipids/phosphatidylglycerol = 82:18, mol/mol). The numbers of high- and low-affinity toxin-binding sites depend strictly on the cholesterol mole percentage in liposomes. High-affinity toxin-binding sites appear only in liposomes with high cholesterol contents. Liposomes whose cholesterol/phospholipid ratio is 0.4 or less have no high-affinity sites regardless of their phospholipid compositions, while low-affinity sites appear in liposomes with lower cholesterol contents. The threshold values for the cholesterol mole percentage above which high-affinity toxin-binding sites appear were examined. The values decrease in accordance with the increase in the mole fraction of 18-carbon hydrocarbon chains among the total 14-18 carbon-hydrocarbon chains of the liposomal phospholipids. Furthermore, both the partial replacement of phosphatidylcholine with phosphatidylethanolamine and the digestion of phospholipids with phospholipase C also affect the threshold values. Thus the cholesterol mole percentage, in combination with phospholipid chain length and other factors, determines the topology of membrane cholesterol providing distinctively different affinity sites for theta-toxin.
Ohno-Iwashita
Y
Y
Department of Membrane Biochemistry, Tokyo Metropolitan Institute of Gerontology, Japan.
Iwamoto
M
M
Ando
S
S
Iwashita
S
S
D001427:Bacterial Toxins / Q000378:metabolism*; D001665:Binding Sites; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D002784:Cholesterol / Q000032:analysis / Q000378:metabolism*; D002789:Cholesterol Oxidase; D003016:Clostridium perfringens; D006460:Hemolysin Proteins; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism*; D008563:Membrane Lipids / Q000494:pharmacology*; D008970:Molecular Weight; D010713:Phosphatidylcholines; D010743:Phospholipids / Q000032:analysis; D010738:Type C Phospholipases
D001427:Bacterial Toxins; D006460:Hemolysin Proteins; D008081:Liposomes; D008563:Membrane Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; C027891:1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine; C020452:Clostridium perfringens theta-toxin; D002784:Cholesterol; D002789:Cholesterol Oxidase; D010738:Type C Phospholipases